Related Experiment Videos
Therapies for chronic hepatitis B: emerging roles for nucleoside analogues
1A W Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW. strassers@rpamail.cs.nsw.gov.au
Australian and New Zealand Journal of Medicine
|December 7, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Liver Frailty Index predicts survival in systemic therapy for hepatocellular carcinoma: a multicentre prospective cohort study.
ESMO gastrointestinal oncology·2026
Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B.
The Journal of infectious diseases·2025
Animal and translational models of SARS-CoV-2 infection and COVID-19.
Mucosal immunology·2020
Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15).
Alimentary pharmacology & therapeutics·2017
A serological re-evaluation of acute non-A non-B hepatitis from the early 1970s.
Australian and New Zealand journal of medicine·2001
Cost-effectiveness and accuracy of exercise stress echocardiography in the non-invasive diagnosis of coronary heart disease.
Australian and New Zealand journal of medicine·2001
A multivariate analysis of the association between social class of origin and current social class with self-rated general health and psychological health among 16-year-old Australians.
Australian and New Zealand journal of medicine·2001
Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland.
Australian and New Zealand journal of medicine·2001
PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.
Journal of hepatocellular carcinoma·2026
Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.
International journal of pharmaceutics: X·2026
N-Terminal polarity reversal of cysteine-terminated peptides: A strategy to develop potent metallo-β-lactamase inhibitors with in vivo efficacy.
European journal of medicinal chemistry·2026
Non-Oncology Biomarkers in Precision Medicine: A Narrative Review.
Therapeutic innovation & regulatory science·2026